Revolutionizing drug development
Do you know what airplane pilots and chemistry lab technicians at Boehringer Ingelheim have in common? They are both using simulators, or so-called ‘digital twins’, to mimic real-life situations in a virtual environment.
Laboratory experiments have always been considered the "gold standard" for drug development. However, the possibilities in the laboratory are limited, especially when it comes to making predictions for large-scale drug production. That's why our scientists in Biberach have harnessed the revolutionary technology of so-called “digital twins”. Based on mathematical algorithms, they have developed models that allow them to simulate real experiments and predict results under conditions that cannot normally be tested in the laboratory environment. Watch how this technology adds immense value to biopharmaceutical drug manufacturing for Boehringer Ingelheim.
Related Content
